Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer
Authors:
- Jonathan I EpsteinJEJonathan I Epstein
- Mahul B AminMAMahul B Amin
- Philipp U HeitzPHPhilipp U Heitz
- Seife HailemariamSHSeife Hailemariam
- 1 September 1999
- journal article
- Published by Elsevier in Human Pathology
- Vol. 30 (9) , 1077-1086
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Adenosis of the Prostate Histologic Features in Transurethral Resection SpecimensAmerican Journal of Surgical Pathology, 1994
- Expression of p160erbB-3 and p185erbB-2 in Prostatic Intraepithelial Neoplasia and Prostatic AdenocarcinomaJNCI: Journal of the National Cancer Institute, 1994
- Bcl-2 and the regulation of programmed cell deathJournal of Cell Biology, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.Journal of Cell Biology, 1992
- Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cellsCell, 1992
- The type 1 (EGFR-related) family of growth factor receptors and their ligandsProgress in Growth Factor Research, 1992
- Expression of c‐erb B‐2/neu proto‐oncogene in human prostatic cancer tissues and cell linesMolecular Carcinogenesis, 1992
- The p53 tumour suppressor geneNature, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990